{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:43:25Z","timestamp":1779911005165,"version":"3.53.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pulmonary lesions inconclusive in <jats:sup>18<\/jats:sup>F-FDG PET\/CT are a known clinical problem. Both texture analysis and <jats:sup>68<\/jats:sup>Ga-FAPI-46 have shown potential in thoracic oncological problems but their combination has not been assessed yet. This initial analysis aims to evaluate the utility of <jats:sup>68<\/jats:sup>Ga-FAPI-46 PET texture parameters to differentiate between lung cancer and benign pulmonary lesions inconclusive in <jats:sup>18<\/jats:sup>F-FDG PET\/CT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>20 histologically confirmed pulmonary lesions (13 lung cancer, 7 benign) in 19 patients were evaluated. All patients underwent an inconclusive <jats:sup>18<\/jats:sup>F-FDG PET\/CT before <jats:sup>68<\/jats:sup>Ga-FAPI-46 PET\/CT. 64 texture parameters and conventional parameters (SUVs, TBRs) were analyzed. Texture parameters with significant (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) differences between lung cancer and benign lesions were detected by the Mann-Whitney U test. Boxplots and a scatter plot matrix were created. Principal component analyses and Spearman correlations were performed. Receiver operating characteristics curves with area under the curve (AUC) values were created for univariable and bivariable logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The texture parameters HIST Maximum grey level (AUC\u2009=\u20090.901), HIST Mean (AUC\u2009=\u20090.802), HIST Mode (AUC\u2009=\u20090.835), HIST Range (AUC\u2009=\u20090.901) and GLCM Information correlation 1 (AUC\u2009=\u20090.824) showed significant differences between lung cancer and benign pulmonary lesions. AUC values of conventional parameters (SUVmax, SUVmean, TBR(SUVmax), TBR(SUVmean)) were 0.791, 0.868, 0.802 and 0.857, respectively. Maximum AUC values of bivariable logistic regression were 0.967 and 0.978 for two texture parameters and the combination of conventional and texture parameters, respectively. Correlations between texture parameter pairs were mainly moderate (0.4\u2264\u03c1\u22640.59). 2\/5 texture parameters (HIST Mean, HIST Mode) displayed no very strong correlations (0.8\u2264\u03c1\u22641.00) to any conventional parameters or lesion volume.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>\n              <jats:sup>68<\/jats:sup>Ga-FAPI-46 PET texture parameters show great potential to differentiate between lung cancer and benign pulmonary lesions inconclusive in <jats:sup>18<\/jats:sup>F-FDG\/PET. Spearman correlations indicate additional information value of texture parameters.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40644-025-00886-w","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T16:29:50Z","timestamp":1749745790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Image analysis: 68Ga-FAPI-46 PET derived texture parameters improve the differentiation of malignant and benign pulmonary lesions"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0273-2183","authenticated-orcid":false,"given":"Joel","family":"Wessendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Spektor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahim","family":"Aboulmaouahib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Daum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik M.","family":"Glatting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Schlamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Grott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Eichhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Peter","family":"Heu\u00dfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Ulrich","family":"Kauczor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Schreckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauke","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"R\u00f6hrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"886_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"886_CR2","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1097\/MD.0000000000000666","volume":"94","author":"M Dabrowska","year":"2015","unstructured":"Dabrowska M, Krenke R, Korczynski P, et al. Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules. Med (Baltim). 2015;94:e666. https:\/\/doi.org\/10.1097\/MD.0000000000000666","journal-title":"Med (Baltim)"},{"key":"886_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3348\/kjr.2006.7.1.57","volume":"7","author":"JM Chang","year":"2006","unstructured":"Chang JM, Lee HJ, Goo JM, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006;7:57\u201369. https:\/\/doi.org\/10.3348\/kjr.2006.7.1.57","journal-title":"Korean J Radiol"},{"key":"886_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1148\/rg.232025705","volume":"23","author":"L Kostakoglu","year":"2003","unstructured":"Kostakoglu L, Agress H, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographics. 2003;23:315\u201340. https:\/\/doi.org\/10.1148\/rg.232025705. quiz 533.","journal-title":"Radiographics"},{"key":"886_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/MNM.0000000000000605","volume":"38","author":"Z Ruilong","year":"2017","unstructured":"Ruilong Z, Daohai X, Li G, et al. Diagnostic value of 18F-FDG-PET\/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis. Nucl Med Commun. 2017;38:67\u201375. https:\/\/doi.org\/10.1097\/MNM.0000000000000605","journal-title":"Nucl Med Commun"},{"key":"886_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.hlc.2021.10.011","volume":"31","author":"F Lococo","year":"2022","unstructured":"Lococo F, Guerrera F, Rena O, et al. Accuracy of 18F-FDG in detecting stage I lung adenocarcinomas according to IASLC\/ATS\/ERS classification. Heart Lung Circ. 2022;31:726\u201332. https:\/\/doi.org\/10.1016\/j.hlc.2021.10.011","journal-title":"Heart Lung Circ"},{"key":"886_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.lungcan.2014.11.010","volume":"87","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Saji H, Shinmyo T, et al. Close association of IASLC\/ATS\/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. Lung Cancer. 2015;87:28\u201333. https:\/\/doi.org\/10.1016\/j.lungcan.2014.11.010","journal-title":"Lung Cancer"},{"key":"886_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/kitp.2018.74667","volume":"15","author":"AG Ergonul","year":"2018","unstructured":"Ergonul AG, Akcam TI, \u00d6zdil A, et al. Diagnostic value of 18F-FDG-PET\/CT in benign lung diseases. Kardiochir Torakochirurgia Pol. 2018;15:1\u20134. https:\/\/doi.org\/10.5114\/kitp.2018.74667","journal-title":"Kardiochir Torakochirurgia Pol"},{"key":"886_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12880-020-00475-2","volume":"20","author":"C Liu","year":"2020","unstructured":"Liu C, Ma C, Duan J, et al. Using CT texture analysis to differentiate between peripheral lung cancer and pulmonary inflammatory pseudotumor. BMC Med Imaging. 2020;20:75. https:\/\/doi.org\/10.1186\/s12880-020-00475-2","journal-title":"BMC Med Imaging"},{"key":"886_CR10","doi-asserted-by":"publisher","first-page":"20170267","DOI":"10.1259\/bjr.20170267","volume":"91","author":"I Phillips","year":"2018","unstructured":"Phillips I, Ajaz M, Ezhil V, et al. Clinical applications of textural analysis in non-small cell lung cancer. Br J Radiol. 2018;91:20170267. https:\/\/doi.org\/10.1259\/bjr.20170267","journal-title":"Br J Radiol"},{"key":"886_CR11","doi-asserted-by":"publisher","first-page":"e0145063","DOI":"10.1371\/journal.pone.0145063","volume":"10","author":"F Orlhac","year":"2015","unstructured":"Orlhac F, Soussan M, Chouahnia K, et al. 18F-FDG PET-derived textural indices reflect tissue-specific uptake pattern in non-small cell lung cancer. PLoS ONE. 2015;10:e0145063. https:\/\/doi.org\/10.1371\/journal.pone.0145063","journal-title":"PLoS ONE"},{"key":"886_CR12","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1007\/s11307-019-01336-3","volume":"21","author":"F Bianconi","year":"2019","unstructured":"Bianconi F, Palumbo I, Fravolini ML, et al. Texture analysis on [18F]FDG PET\/CT in non-small-cell lung cancer: correlations between PET features, CT features, and histological types. Mol Imaging Biol. 2019;21:1200\u20139. https:\/\/doi.org\/10.1007\/s11307-019-01336-3","journal-title":"Mol Imaging Biol"},{"key":"886_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.remnie.2020.09.012","volume":"40","author":"U Aydos","year":"2021","unstructured":"Aydos U, \u00dcnal ER, \u00d6z\u00e7elik M, et al. Texture features of primary tumor on 18F-FDG PET images in non-small cell lung cancer: the relationship between imaging and histopathological parameters. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021;40:343\u201350. https:\/\/doi.org\/10.1016\/j.remnie.2020.09.012","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"886_CR14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ijrobp.2014.07.020","volume":"90","author":"DV Fried","year":"2014","unstructured":"Fried DV, Tucker SL, Zhou S, et al. Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung Cancer. Int J Radiat Oncol Biol Phys. 2014;90:834\u201342. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"886_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00259-016-3314-8","volume":"43","author":"P Lovinfosse","year":"2016","unstructured":"Lovinfosse P, Janvary ZL, Coucke P, et al. FDG PET\/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. Eur J Nucl Med Mol Imaging. 2016;43:1453\u201360. https:\/\/doi.org\/10.1007\/s00259-016-3314-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"886_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1148\/radiol.2015142920","volume":"278","author":"DV Fried","year":"2016","unstructured":"Fried DV, Mawlawi O, Zhang L, et al. Stage III Non-Small cell lung cancer: prognostic value of FDG PET quantitative imaging features combined with clinical prognostic factors. Radiology. 2016;278:214\u201322. https:\/\/doi.org\/10.1148\/radiol.2015142920","journal-title":"Radiology"},{"key":"886_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1148\/radiol.2015141309","volume":"276","author":"GJR Cook","year":"2015","unstructured":"Cook GJR, O\u2019Brien ME, Siddique M, et al. Non-small cell lung cancer treated with erlotinib: heterogeneity of (18)F-FDG uptake at PET-association with treatment response and prognosis. Radiology. 2015;276:883\u201393. https:\/\/doi.org\/10.1148\/radiol.2015141309","journal-title":"Radiology"},{"key":"886_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4274\/mirt.galenos.2021.79037","volume":"31","author":"H \u00d6nner","year":"2022","unstructured":"\u00d6nner H, Co\u015fkun N, Erol M, Eren Karanis M\u0130. The role of histogram-based textural analysis of 18F-FDG PET\/CT in evaluating tumor heterogeneity and predicting the prognosis of invasive lung adenocarcinoma. Mol Imaging Radionucl Ther. 2022;31:33\u201341. https:\/\/doi.org\/10.4274\/mirt.galenos.2021.79037","journal-title":"Mol Imaging Radionucl Ther"},{"key":"886_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1158\/1535-7163.MCT-11-0340","volume":"11","author":"WN Brennen","year":"2012","unstructured":"Brennen WN, Isaacs JT, Denmeade SR. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy. Mol Cancer Ther. 2012;11:257\u201366. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0340","journal-title":"Mol Cancer Ther"},{"key":"886_CR20","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59:1423\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.210435","journal-title":"J Nucl Med"},{"key":"886_CR21","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1007\/s00259-022-05754-4","volume":"49","author":"X Chen","year":"2022","unstructured":"Chen X, Liu X, Wang L, et al. Expression of fibroblast activation protein in lung cancer and its correlation with tumor glucose metabolism and histopathology. Eur J Nucl Med Mol Imaging. 2022;49:2938\u201348. https:\/\/doi.org\/10.1007\/s00259-022-05754-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"886_CR22","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2967\/jnumed.123.267103","volume":"65","author":"M R\u00f6hrich","year":"2024","unstructured":"R\u00f6hrich M, Daum J, Gutjahr E, et al. Diagnostic potential of supplemental static and dynamic 68Ga-FAPI-46 PET for primary 18F-FDG-negative pulmonary lesions. J Nucl Med. 2024;65:872\u20139. https:\/\/doi.org\/10.2967\/jnumed.123.267103","journal-title":"J Nucl Med"},{"key":"886_CR23","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1148\/rg.2018180017","volume":"38","author":"J Bueno","year":"2018","unstructured":"Bueno J, Landeras L, Chung JH. Updated Fleischner society guidelines for managing incidental pulmonary nodules: common questions and challenging scenarios. Radiographics. 2018;38:1337\u201350. https:\/\/doi.org\/10.1148\/rg.2018180017","journal-title":"Radiographics"},{"key":"886_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2967\/jnumed.121.261925","volume":"63","author":"M R\u00f6hrich","year":"2022","unstructured":"R\u00f6hrich M, Leitz D, Glatting FM, et al. Fibroblast activation protein-specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study. J Nucl Med. 2022;63:127\u201333. https:\/\/doi.org\/10.2967\/jnumed.121.261925","journal-title":"J Nucl Med"},{"key":"886_CR25","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/s0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373\u20139. https:\/\/doi.org\/10.1016\/s0895-4356(96)00236-3","journal-title":"J Clin Epidemiol"},{"key":"886_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1148\/radiol.211424","volume":"303","author":"L Wang","year":"2022","unstructured":"Wang L, Tang G, Hu K, et al. Comparison of 68Ga-FAPI and 18F-FDG PET\/CT in the evaluation of advanced lung cancer. Radiology. 2022;303:191\u20139. https:\/\/doi.org\/10.1148\/radiol.211424","journal-title":"Radiology"},{"key":"886_CR27","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47:1820\u201332. https:\/\/doi.org\/10.1007\/s00259-020-04769-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"886_CR28","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.2967\/jnumed.123.266046","volume":"64","author":"SA Koerber","year":"2023","unstructured":"Koerber SA, R\u00f6hrich M, Walkenbach L, et al. Impact of 68Ga-FAPI PET\/CT on staging and oncologic management in a cohort of 226 patients with various cancers. J Nucl Med. 2023;64:1712\u201320. https:\/\/doi.org\/10.2967\/jnumed.123.266046","journal-title":"J Nucl Med"},{"key":"886_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.arbr.2013.09.013","volume":"50","author":"\u00c1 Taus","year":"2014","unstructured":"Taus \u00c1, Aguil\u00f3 R, Curull V, et al. Impact of 18F-FDG PET\/CT on the treatment of patients with non-small cell lung cancer. Arch Bronconeumol. 2014;50:99\u2013104. https:\/\/doi.org\/10.1016\/j.arbr.2013.09.013","journal-title":"Arch Bronconeumol"},{"key":"886_CR30","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1007\/s00330-020-07619-6","volume":"31","author":"M Pi\u00f1eiro-Fiel","year":"2021","unstructured":"Pi\u00f1eiro-Fiel M, Moscoso A, Lado-Cacheiro L, et al. Correction to: is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer? Eur Radiol. 2021;31:4412\u20134412. https:\/\/doi.org\/10.1007\/s00330-020-07619-6","journal-title":"Eur Radiol"},{"key":"886_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2967\/jnumed.122.264361","volume":"64","author":"M Lang","year":"2023","unstructured":"Lang M, Spektor A-M, Hielscher T, et al. Static and dynamic 68Ga-FAPI PET\/CT for the detection of malignant transformation of intraductal papillary mucinous neoplasia of the pancreas. J Nucl Med. 2023;64:244\u201351. https:\/\/doi.org\/10.2967\/jnumed.122.264361","journal-title":"J Nucl Med"},{"key":"886_CR32","doi-asserted-by":"publisher","first-page":"17848","DOI":"10.1038\/s41598-023-43049-2","volume":"13","author":"J Hoppner","year":"2023","unstructured":"Hoppner J, van Genabith L, Hielscher T, et al. Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas. Sci Rep. 2023;13:17848. https:\/\/doi.org\/10.1038\/s41598-023-43049-2","journal-title":"Sci Rep"},{"key":"886_CR33","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.3390\/ijms25137197","volume":"25","author":"F Manuppella","year":"2024","unstructured":"Manuppella F, Pisano G, Taralli S, et al. Diagnostic performances of PET\/CT using fibroblast activation protein inhibitors in patients with primary and metastatic liver tumors: a comprehensive literature review. Int J Mol Sci. 2024;25:7197. https:\/\/doi.org\/10.3390\/ijms25137197","journal-title":"Int J Mol Sci"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00886-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T16:29:51Z","timestamp":1749745791000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-025-00886-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["886"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00886-w","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants confirmed to the ethical standards of the institutional and\/or national research committee and to the Helsinki declaration (1964) and its later amendments or comparable ethical standards. This retrospective study was approved by the local advisory ethic committee (study number S-115\/2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients have given written consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"U.H. has filed a patent application for quinoline-based FAP-targeting agents for imaging and therapy in nuclear medicine. U.H. also has shares of a consultancy group for iTheranostics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}